U.S. flag

An official website of the United States government

NM_000238.4(KCNH2):c.56T>C (p.Ile19Thr) AND Long QT syndrome 2

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 17, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004595409.1

Allele description [Variation Report for NM_000238.4(KCNH2):c.56T>C (p.Ile19Thr)]

NM_000238.4(KCNH2):c.56T>C (p.Ile19Thr)

Gene:
KCNH2:potassium voltage-gated channel subfamily H member 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q36.1
Genomic location:
Preferred name:
NM_000238.4(KCNH2):c.56T>C (p.Ile19Thr)
HGVS:
  • NC_000007.14:g.150977858A>G
  • NG_008916.1:g.5069T>C
  • NM_000238.4:c.56T>CMANE SELECT
  • NM_172056.3:c.56T>C
  • NP_000229.1:p.Ile19Thr
  • NP_000229.1:p.Ile19Thr
  • NP_742053.1:p.Ile19Thr
  • NP_742053.1:p.Ile19Thr
  • LRG_288t1:c.56T>C
  • LRG_288t2:c.56T>C
  • LRG_288:g.5069T>C
  • LRG_288p1:p.Ile19Thr
  • LRG_288p2:p.Ile19Thr
  • NC_000007.13:g.150674946A>G
  • NM_000238.3:c.56T>C
  • NM_172056.2:c.56T>C
  • NR_176254.1:n.464T>C
Protein change:
I19T
Molecular consequence:
  • NM_000238.4:c.56T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_172056.3:c.56T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_176254.1:n.464T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Long QT syndrome 2 (LQT2)
Identifiers:
MONDO: MONDO:0013367; MedGen: C3150943; Orphanet: 101016; Orphanet: 768; OMIM: 613688

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005086703Victorian Clinical Genetics Services, Murdoch Childrens Research Institute

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jul 17, 2023)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The dominant negative LQT2 mutation A561V reduces wild-type HERG expression.

Kagan A, Yu Z, Fishman GI, McDonald TV.

J Biol Chem. 2000 Apr 14;275(15):11241-8.

PubMed [citation]
PMID:
10753933

Long QT Syndrome Overview..

Groffen AJ, Bikker H, Christiaans I.

2003 Feb 20 [updated 2024 Mar 21]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301308
See all PubMed Citations (9)

Details of each submission

From Victorian Clinical Genetics Services, Murdoch Childrens Research Institute, SCV005086703.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as VUS-3A. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with long QT syndrome 2 (MIM#613688). Gain of function is also a known mechanism associated with short QT syndrome 1 (MIM#609620) (OMIM, PMIDs: 10753933, 21777565). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance (PMID: 20301308). (I) 0200 - Variant is predicted to result in a missense amino acid change from isoleucine to threonine. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools but uninformative conservation with a moderate amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0708 - Another missense variant comparable to the one identified in this case has conflicting previous evidence for pathogenicity. p.(Ile19Phe) has been detected in individuals with LQTS (ClinVar, PMIDs: 32893267, 31520628). It has been reported as a VUS in ClinVar in a family with segregation evidence (personal communication). However, a study utilising an adapted version of the ACMG guidelines, has regarded it as likely pathogenic (PMID: 32893267). (I) 0808 - Previous reports of pathogenicity for this variant are conflicting. It has been detected in at least two families with LQTS and regarded as a VUS, including a de novo occurrence in an individual with LQTS who also harbours a variant of uncertain significance with potential clinical relevance (VUS-3A) in KCNQ1 (PMID: 26669661; LOVD; VCGS cohort). A study utilising an adapted version of the ACMG guidelines, has regarded it as likely pathogenic (PMID: 32893267). (I) 0905 - No published segregation evidence has been identified for this variant. This variant has been reported in a family; however, no sufficient information was provided to inform segregation (PMID: 26669661; LOVD). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 4, 2024